Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RIVN vs GSK✓SelectedUSD · GSKRIVN vs GSK performance historyLatest closeAs of-0.66%11/16
Stock and ETF performance explorer

RIVN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.2%
GSK return
+64.4%
Excess return
-90.6%
Maximum drawdown
-65.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.6%
7D-13.6%-1.3%-12.3%-13.5%
30D-2.6%+2.7%-5.3%-2.8%
3M-21.2%+2.7%-23.9%-21.4%
6M-12.3%+3.3%-15.6%-12.6%
YTD-38.6%+6.5%-45.1%-38.9%
1Y-19.9%+10.7%-30.6%-20.5%
3Y-26.2%+64.4%-90.5%-30.9%
All-26.2%+64.4%-90.6%-30.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling